Jane Street Group, LLC Eye Point Pharmaceuticals, Inc. Transaction History
Jane Street Group, LLC
- $72.9 Billion
- Q1 2024
A detailed history of Jane Street Group, LLC transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 214,694 shares of EYPT stock, worth $1.87 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
214,694
Previous 69,895
207.17%
Holding current value
$1.87 Million
Previous $1.62 Million
174.74%
% of portfolio
0.01%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding EYPT
# of Institutions
176Shares Held
53.9MCall Options Held
764KPut Options Held
1.57M-
Cormorant Asset Management, LP Boston, MA6.89MShares$60 Million8.2% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.76MShares$41.4 Million0.19% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.76MShares$32.7 Million3.33% of portfolio
-
Franklin Resources Inc San Mateo, CA3.39MShares$29.5 Million0.02% of portfolio
-
Black Rock Inc. New York, NY2.79MShares$24.3 Million0.0% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $296M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...